(Q36465191)

English

Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration (English)

1 reference

Europe PubMed Central

14 August 2017

pharmacogenomics

1 reference

based on heuristic

inferred from title

author name string

Kathryn A Phillips

1

1 reference

Europe PubMed Central

14 August 2017

Stephanie L Van Bebber

2

1 reference

Europe PubMed Central

14 August 2017

publication date

1 June 2006

1 reference

Europe PubMed Central

14 August 2017

Medical Care Research and Review

1 reference

Europe PubMed Central

14 August 2017

63

1 reference

Europe PubMed Central

14 August 2017

3

1 reference

Europe PubMed Central

14 August 2017

301-326

1 reference

Europe PubMed Central

14 August 2017

With your genes? Take one of these, three times a day

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Adverse drug event monitoring at the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

The political economy of FDA drug review: processing, politics, and lessons for policy

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

A vision for the future of genomics research

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

The economics of gene therapy and of pharmacogenetics

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Moving towards individualized medicine with pharmacogenomics

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Clinical biomarkers in drug discovery and development

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Toxicogenomics data: the road to acceptance

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Limitations of direct-to-consumer advertising for clinical genetic testing

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Microarray data--the US FDA, industry and academia

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

FDA seeks genome-based drug data

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Ethical perspectives on pharmacogenomic profiling in the drug development process

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe Workshop

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Pharmacogenetics and the future of medical practice

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Preventing Toxicity With a Gene Test

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

4th Annual Pharmacogenomics and Medicine Lectures

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Medical applications of microarray technologies: a regulatory science perspective

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Potential use of home HIV testing

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Consent and privacy in pharmacogenetic testing.

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Promotion of prescription drugs to consumers.

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Pharmacogenetics and the practice of medicine

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Pharmacogenetics and drug development: the path to safer and more effective drugs

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Microarray technology--an intellectual property retrospective

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) Proposal

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

FDA guidance on pharmacogenomics data submission

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Beyond release: the equitable use of genomic information.

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

What is next in pharmacogenomics? Translating it to clinical practice

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Pharmacogenetics and public policy: expert views in Europe and North America

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Regulatory options for pharmacogenetics

1 reference

https://api.crossref.org/works/10.1177%2F1077558706287020

21 January 2018

Identifiers

10.1177/1077558706287020

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36465191&oldid=1632514069"